Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Receivables (2016 - 2025)

Historic Receivables for Bruker (BRKR) over the last 17 years, with Q3 2025 value amounting to $669.5 million.

  • Bruker's Receivables rose 362.17% to $669.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $669.5 million, marking a year-over-year increase of 362.17%. This contributed to the annual value of $659.1 million for FY2024, which is 1470.59% up from last year.
  • Per Bruker's latest filing, its Receivables stood at $669.5 million for Q3 2025, which was up 362.17% from $649.7 million recorded in Q2 2025.
  • Bruker's Receivables' 5-year high stood at $669.5 million during Q3 2025, with a 5-year trough of $374.8 million in Q1 2021.
  • Over the past 5 years, Bruker's median Receivables value was $538.8 million (recorded in 2023), while the average stood at $539.2 million.
  • Its Receivables has fluctuated over the past 5 years, first surged by 234.84% in 2021, then soared by 2278.55% in 2022.
  • Quarter analysis of 5 years shows Bruker's Receivables stood at $463.0 million in 2021, then increased by 15.33% to $534.0 million in 2022, then increased by 7.6% to $574.6 million in 2023, then increased by 14.71% to $659.1 million in 2024, then grew by 1.58% to $669.5 million in 2025.
  • Its Receivables was $669.5 million in Q3 2025, compared to $649.7 million in Q2 2025 and $635.1 million in Q1 2025.